Development of a chimeric antigen receptor T cell therapy platform at the Mayo Clinic

Grant Project Details:

Awardee:
Saad Kenderian, MD
Timeframe:
2017-2018
Location:
Mayo Clinic | Rochester, MN
Amount:
$100,000
Status:
In Process
View all grants awarded

Grant timeline: proposal, updates, reports

Grant Location

Mayo Clinic
200 First Street SW
Rochester, MN 55905

Grant Description

The goal of this project is to establish the infrastructure for the development of chimeric antigen receptor T (CART) cell therapy at the Mayo Clinic. CART cell therapy has emerged as a potent and potentially curative modality for the treatment of cancer. The technology engineers T cells to make them recognize cancer cells and therefore can be a platform used for the treatment of multiple solid and hematological malignancies. The ultimate goal is to develop a regenerative medicine service line using engineered T cells for the treatment of cancer.